Axsome Therapeutics, Inc. (AXSM)
219.01
-3.62
(-1.63%)
USD |
NASDAQ |
May 07, 09:44
Axsome Therapeutics Cash from Investing (Quarterly) : -0.121M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Merck & Co., Inc. | -10.21B |
| Madrigal Pharmaceuticals, Inc. | 192.19M |
| Insmed, Inc. | 389.41M |
| AnaptysBio, Inc. | 73.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.70M |
| Cash from Financing (Quarterly) | 2.994M |
| Free Cash Flow | -70.99M |
| Free Cash Flow Per Share (Quarterly) | -0.4067 |
| Free Cash Flow to Equity (Quarterly) | -22.61M |
| Free Cash Flow to Firm (Quarterly) | -17.73M |
| Free Cash Flow Yield | -0.64% |